PT-141

PT-141 (Bremelanotide) – High-Purity Research Peptide

PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist extensively studied for its interaction with melanocortin signaling pathways involved in neurological, endocrine, and physiological regulatory processes. Originally derived from Melanotan II research, PT-141 has become a valuable compound in laboratory investigations focused on receptor activation, neuropeptide signaling, and melanocortin-mediated biological responses.

Our PT-141 is manufactured using advanced solid-phase peptide synthesis (SPPS) and purified to achieve ≥99% purity, verified through high-performance liquid chromatography (HPLC) and mass spectrometry (MS). Every batch undergoes rigorous quality control testing to confirm molecular identity, purity, stability, and consistency, ensuring reliable performance across research applications.

Supplied as a sterile, lyophilized powder, PT-141 is formulated for maximum stability during storage and transport under controlled laboratory conditions. Its well-characterized receptor activity and extensive research background make it a valuable tool for studies involving melanocortin pathways, neuroendocrine signaling, and receptor-ligand interactions.

Key Characteristics:
• PT-141 (Bremelanotide) research peptide
• ≥99% purity verified via HPLC/MS
• Synthesized using precision SPPS technology
• Studied for melanocortin receptor pathway research
• Lyophilized for enhanced stability and storage
• Batch-tested for identity, purity, and consistency

Important Notice:
This product is intended for research purposes only. Not for human consumption, medical use, or veterinary use.